跳至主要内容
临床试验/EUCTR2021-006632-67-FR
EUCTR2021-006632-67-FR进行中(未招募)1 期

Alkalinization of adrenalized lidocaine in extending epidural analgesia for extremely urgent cesarean section during labor: a randomized controlled trial. - QETA

CHU de Bordeaux0 个研究点目标入组 66 人开始时间: 2022年1月31日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Adult patients,
  • - Affiliated to social security
  • - Informed consent signed by the participant and the investigating physician at the latest after the therapeutic intervention
  • - Initial indication for vaginal delivery
  • - Benefiting from emergency caesarean section during labour for fetal extraction with a maximum 15-minute decision-to-delivery delay (i.e. code red Caesarean section)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 66
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Opposition to participation in research before delivery
  • - Refusal or impossibility of informed consent
  • - Lack of understanding or significant language barrier
  • - Initial indication for general anaesthesia defined by the following situations: non-functional epidural analgesia, altered consciousness, eclampsia, suspicion of amniotic embolism, confirmed or suspected severe haemorrhage occurring before birth
  • - Contraindication to the use of the products defined in the protocol : lidocaïne
  • - Persons placed under judicial protection

研究者

发起方
CHU de Bordeaux

相似试验

Alkalinization of adrenalized lidocaine in extending... | 临床试验